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The anti-inflammatory and anti-nociceptive activities of the root extract of Elephantorrhiza elephantina 
(Burch.) Skeels (Fabaceae) were investigated using wistar rats. The extract was administered 
intraperitoneally (i.p) to rats at graded doses of 50, 100 and 200 mg/kg BWt.  Carrageenan and 
Histamine were injected into rat paws sub-plantar to induce paw oedema, while acetic acid and formalin 
were injected i.p to induce pain. Indomethacin (10 mg/kg) was used as reference drug, whereas the 
vehicle [0.9% normal saline in 3% tween 80 (2 ml/kg)] was used as negative control. Acute toxicity was 
tested in rats at doses of 200, 400, 800 and 1600 mg/kg BWt. Compared to control, the aqueous extract 
of E. elephantina at all doses investigated significantly (P < 0.05) reduced the formation of oedema 
induced by Carrageenan and Histamine. The extract also caused a significant (P < 0.05) reduction in 
writhings in the acetic acid test and licking time in the formalin test. The rats did not show any signs of 
acute toxicity. The study revealed the anti-inflammatory and anti-nociceptive activities of the aqueous 
extract of E. elephantina, which may be due to the presence of phytochemical constituents such as 
tannins and flavonoids. The acute toxicity test showed that the plant is relatively safe to use.  
 





Chronic inflammatory diseases remain one of the world’s 
major health problems (Adedapo et al., 2008); as a result, 
it has become the focus of global scientific research. In-
flammation is the response of living tissue to injury, 
involving a complex array of enzyme activation, mediator 
release, extravasations of fluid, cell migration, tissue 
breakdown and repair (Perianayagam et al., 2006). As a 
result of adverse effects such as gastric lesions caused 
by non-steroidal anti-inflammatory drugs (NSAID), tole-
rance and dependence induced by opiates, use of these 
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have not been successful in all cases (Adedapo et al., 
2008). New anti-inflammatory and analgesic drugs with-
out these side effects are therefore being researched as 
alternatives to NSAID and opiates. Attention is focused 
on investigating efficacy of plant-based drugs used in 
traditional medicine because they are cheap, have little 
side effects and according to WHO, about 80% of the 
world population still rely mainly on herbal remedies 
(Adedapo et al., 2008). 
Elephantorrhiza elephantina (Burch.) Skeels. (Faba-
ceae) is a traditional remedy for a wide range of ailments 
both in humans and livestock. Among Zulus, an infusion 
of the inner parts of the roots is administered as an 
enema for dysentery and diarrhoea and root decoctions 
are also taken for diarrhoea (Hutchings et al., 1996). In 






Cocks, 2001); heartwater, blackquarter, (Luseba and Van 
der Merwe 2006); diarrhoea, coughing, pneumonia, as 
well as tick-borne diseases (McGaw and Ellof, 2008). 
Goats are given root decoction to treat helminthosis, 
(Maphosa and Masika, unpublished data).  
Phytochemical screenings have shown the presence of 
catechins in rhizhomes, thus indicating presence of 
condensed tannins, as well as flavanoids and other 
phenolic substances (Naidoo, 2005). Studies have shown 
that tannins are useful in treating dermatitis and are 
known to form a protective layer on the skin and mucosa, 
thereby enhancing tissue regeneration (Van Wyk et al., 
1997). The purpose of this study was therefore, to assess 
the anti-inflammatory and anti-nociceptive activities of E. 
elephantina, so as to validate its ethno-veterinary use. 
 
 
MATERIALS AND METHODS 
 
Plant material collection and extract preparation 
 
Roots were collected in February 2007 in the Matatiele area, Umzi-
mvubu municipality of the eastern Cape province of South Africa. 
The area falls within the latitudes 30º25´ - 33º45´S and longitudes 
23º15´-30º10´E. The plant was identified in its vernacular name by 
farmers and authenticated at Albany Museum herbarium in 
Grahamstown. A voucher specimen (No VMAP18) was deposited in 
the Griffen herbarium, university of Fort Hare.  
The roots were then air dried to constant weights at room tem-
perature and ground into powder. The powder, (100 g) was boiled 
in water (1000 ml) under atmospheric pressure and the solution fil-
tered using a Buckner funnel and Whatman No 1 filter paper. The 






Male Wistar rats, (200-240 g) were used for anti-inflammatory and 
toxicity studies and (90-110 g) for analgesic studies. Animals were 
maintained in the experimental animal house at the university of 
Fort Hare, South Africa, under room temperature (25ºC) and normal 
day light. They were kept in rat cages, fed on commercial pellets 
(EPOL Feeds, South Africa Ltd.) ad libitum, and allowed free ac-
cess to clean water in bottles. All experimental protocols were in 
compliance with university of Fort Hare ethics committee on 
research in animals, as well as internationally accepted principles 
for laboratory animal use and care. 
 
 
Chemicals and drugs 
 
Carrageenan, histamine, acetic acid, tween- 80 and indomethacin, 
all of analytical grade, were obtained from sigma-Aldrich Chemie 
Gmbh, Steinheim, Denmark.  
 
 
Acute toxicity test 
 
Using method of Hilaly et al., (2004), sixteen rats were randomly 
grouped into 4 and fasted for 16 h. Graded doses of the extract 
(200, 400, 800 and 1600 mg/kg p.o.) were administered to rats 
using a bulbed  steel  needle. All  animals  were  later  allowed  free  




access to food and water and observed over 48 h, for physiological 
and behavioural changes and deaths.  
 
 
Anti-inflammatory activities: Carrageenan-induced rat paw 
oedema 
 
5 groups each consisting of 4 rats received either plant extract (50, 
100, 200 mg/kg p.o), indomethacin (10 mg/kg p.o), or vehicle 
control [0.9% normal saline in 3% Tween 80 (2 ml/kg). 1 h later, 
acute inflammation was produced by the sub-plantar administration 
of 0.1 ml of 1% Carrageenan (in normal saline containing Tween-
80) in the right hind paw of the rats. Paw volume was measured at 
0, 1, 2 and 3 h after Carrageenan injection using a micrometer 
screw gauge. Increases in the linear diameter of the right hind paws 
of rats were taken as an indication of paw oedema. The percentage 
inhibition of the inflammation was calculated from the expression:  
 
% inhibition = [(D0-Dt)/D0] x 100  
 
where D0 is the average inflammation (hind paw oedema) of rats in 
the control group at a given time and Dt is the average inflammation 
of the drug treated (that is, extracts or indomethacin) rats at the 
same time (Gunakunru et al., 2004).  
 
 
Histamine-induced rat paw oedema 
 
Using the method of Parmar and Ghosh (1978), 5 groups of 4 rats 
each received either plant extract (50, 100, 200 mg/kg i.p), or 
indomethacin (10 mg/kg i.p) or vehicle control [0.9% normal saline 
in Tween 80 (2 ml/kg] i.p. Paw oedema was produced by sub-
plantar injection of 0.1% Histamine into the right hind paw of rats 1 
h after injection of drugs. Paw volume was recorded before hista-
mine injection (time 0) and 1, 2 and 3h after injection. The percen-
tage inhibition of the oedema was calculated using the same 
formula as in Carrageenanan -induced paw oedema. 
 
 
Anti-nociceptive activity: acetic acid-induced writhing test 
 
The test was determined according to the method of Zakaria et al. 
(2001). 5 groups with 4 rats each, received either plant extract (50, 
100, 200 mg/kg), indomethacin (10 mg/kg) or normal saline solution 
(2 ml/kg) (all i.p). 30 min later, 10 ml/kg of acetic acid (0.7%) was 
injected i.p on rats to induce writhing. 10 min later, rats were placed 
in transparent boxes and writhes counted for a period of 10 min. 
Writhing was accepted as contraction of the abdominal muscles 
accompanied by stretching of hind limbs in response to pain. Anti-
nociceptive effect was expressed as reduction of number of writhes 
between control and treated groups, using the formula: [(C-D)/C] x 
100 where C is the average number of writhings for control group of 
rats and D is the average writhings of the drug/extract treated rats 





The method described by Hunskaar et al. (1985) was used. 5 
groups of 4 rats were pretreated with either distilled water vehicle (2 
ml/kg); plant extract (50, 100, 200 mg/kg) or indomethacin (10 
mg/kg) i.p. Thirty minutes later, 2.5% formalin (0.05 ml) was 
injected sub-planter into the dorsal surface of the right hind paw. 
Animals were then placed in transparent boxes and observed 
immediately after injection. Time (seconds) spent licking and biting 
the injected paw was taken  as  an  indicator  of  response  to  pain,  
 




Table 1. Anti-inflammatory activities of aqueous extract of E. elephantina root and indomethacin on 




Paw oedema volume (ml) 
1h 2h 3h 
Control - 1.91 ± 0.14 1.87 ± 0.94 2.05 ± 0.28 
Indomethacin 10 0.74 ± 0.32* (61.3) 0.59 ± 0.34* (68.4) 0.52 ± 0.26* (74.6) 
Extract 50 0.70 ± 0.37* (63.3) 0.32 ± 0.23* (82.9) 0.13 ± 0.05* (93.7) 
Extract 100 0.58 ± 0.29* (69.6) 0.40 ± 0.27* (78.6) 0.98 ± 0.54* (52.0) 
Extract 200 0.55 ± 0.18* (71.2) 0.38 ± 0.30* (79.7) 0.24 ± 0.10* (88.3) 
 
Data in mean ± SD., n = 4.    
Percentage inhibitions of the carrageenan-induced inflammation (oedema) are indicated a (%). 




Table 2. Anti-inflammatory activities of aqueous extract of E. elephantina root and indomethacin 




Paw oedema volume (ml) 
1h 2h 3h 
Control - 1.99±0.34 2.9±0.32 2.57±0.98 
Indomethacin 10 1.72± 0.44 (13.6) 2.22±0.39 (23.4) 1.43±0.29* (44.4) 
Extract 50 1.62±0.51 (18.6) 1.67±0.42* (42.4) 1.18±0.37* (54.1 
Extract 100 1.35±0.82 (32.2) 1.04±0.46* (64.1) 0.65±0.37* (74.7) 
Extract 200 1.68±0.82 (15.6) 1.34±0.74* (53.8) 0.84±0.45* (67.3) 
 
Data in mean ± SD., n = 4.   
Percentage inhibitions of the histamine-induced inflammation (oedema) are indicated a (%). 




which were measured for 5 min (first phase) and 15-30 min (second 





The data were expressed as means ± S.D. Differences between 
control and treatment groups were analyzed using one way ANOVA 
followed by Turkey post hoc multiple comparisons tests using SPSS 





Carrageenan-induced paw oedema 
 
There was a significant (P < 0.05) inhibition of the paw 
oedema in all doses of the plant extract and with indo-
methacin. Doses of 50 mg/kg (63.3-93.7% inhibition) 100 
mg/kg (69.6-78.6% inhibition) and 200 mg/kg (71.2-
88.3% inhibition) were more active than that of indo-
methacin (61.3-74.6% inhibition) (Table 1).  
 
 
Histamine-induced paw oedema  
 
The plant extract  produced  significant (P < 0.05)   reduc- 
 
tion of paw oedema with all doses after 2 and 3h of 
histamine injection (Table 2). Indomethacin produced its 
significant (P < 0.05) anti-inflammatory activity (44.4% 
inhibition) after 3 h of histamine injection. At all test 
levels, the extract was more active than indomethacin. 
 
 
Acetic acid-induced writhing test 
 
The aqueous extract of E. elephantina at 100 and 200 
mg/kg doses significantly (P < 0.05) decreased the 
number of writhes when compared to the control. The ex-
tract at 50 mg/kg exhibited the lowest analgesic effect 





At doses of 100 and 200 mg/kg, E. elephantina caused a 
significant (P < 0.05) reduction in licking time that was 
greater than indomethacin (10 mg/kg) both in the early 
and late phases (Table 4). The extract also exhibited 
higher (88.6%) inhibition at 200 mg/kg dose in the early 
phase and (61.0, 87.0%) in the late phase at 100 and 200  
 




Table 3. Analgesic effect of aqueous extract of E. elephantina root and 




Number of writhing 
per 20 min 
Inhibition 
(%) 
Control 2 6.5 ± 4.4 0 
Indomethacin 10 3.5 ± 1.3* 46.2 
Extract 50 3.0 ± 1.6* 53.8 
Extract 100 1.8 ± 0.5* 72.3 
Extract 200 1.5 ± 0.9* 76.9 
 
Data in mean ± SD., n = 4. 




Table 4. Analgesic effect of the aqueous extract of E. elephantina and indomethacin on formalin 










(15 - 30 min) 
Inhibition 
(%) 
Control - 8.75 ± 2.8 0 19.25 ± 0.9 0 
Indomethacin 10 4.25 ± 1.6 51.4 12.5 ± 5.2 35.1 
Extract 50 5.25 ± 2.1 40.0 14.0 ± 4.8 27.3 
Extract 100 4.25 ± 1.2 51.4 7.5 ± 2.9* 61.0 
Extract 200 1.0 ± 0.2* 88.6 2.5 ± 0.3* 87.0 
 
Data in mean ± SD., n = 4. 




mg/kg respectively than indomethacin (51.4%) in early 
phase, (35.1%) in the late phase.  
 
 
Acute toxicity test 
 
No physiological and behavioural changes were obser-





The anti-inflammatory and analgesic activities of the 
aqueous extract of E. elephantina were established by 
this study. The plant is employed locally in treatment of 
helminthosis and this could probably be attributable to its 
anti-inflammatory and anti-nociceptive activity. The ex-
tract reduced oedema and pain even better than Indo-
methacin, a potent inhibitor of prostaglandins (PG) syn-
thesis (Barros et al., 2006), showing that the plant has 
strong anti-inflammatory and anti-nociceptive activities.  
The suppression of Carrageenan-induced paw oedema 
at the early phase of inflammation can be attributed to 
inhibition of PG synthesis and antihistamine activities by 
the plant extract.  
The suppression of oedema produced  by  histamine  in  
the second and third hour by all doses of the extract sug-
gests that the extract do possess some anti-inflammatory 
activity. Histamine is one of the important mediators of in-
flammation, a potent vasodilator substance and increases 
vascular permeability (Vesudevan et al., 2007). Results 
indicate that the inhibitory effect of E. elephantina root 
aqueous extract on Carrageenan oedema is probably 
due to histamine reduction since the extract was able to 
inhibit the oedema induced by this mediator. It is, there-
fore, speculated that part of the anti-oedematous effect 
by all doses of the extract is due to inhibition of prostag-
landin liberation, since the plant extract effect on Carra-
geenan oedema was more pronounced than that of 
histamine. 
A dose-dependant decrease in writhings by rats inject-
ted with acetic acid signifies the analgesic effect of the 
plant extract. In the acetic acid-induced abdominal 
writhing, which is the visceral pain model, the processor 
releases arachidonic acid via cyclooxygenase and 
prostaglandin biosynthesis plays a role in the nociceptive 
mechanism (Gupta et al., 2005). The anti-nociceptive 
effect of the extract may be due to inhibition of synthesis 
of the arachidonic acid metabolite, mediated by cyclo-
oxygenase inhibition. It is known that the abdominal 
constriction response is very sensitive and able to detect 
anti-nociceptive effect of extracts or compounds that may  
 




appear inactive in other methods like the tail-flick test 
(Spereni et al., 2005). 
The pain in the early phase of formalin test may be due 
to direct stimulation of sensory nerve fibres by formalin, 
while pain in the late phase is due to inflammatory media-
tors like histamine, PGs, serotonin and bradykinin. This 
test is believed to be a more valid analgesic model which 
is better correlated with clinical pain (Tjolsen et al., 1992). 
The decrease in licking time and frequency by rats inject-
ted with formalin therefore signifies the analgesic effect of 
the plant. 
Phytochemically, catechins in rhizhomes have been 
reported, indicating that the plant may contain condensed 
tannins, as well as flavonoids and other phenolic sustan-
ces (Naidoo, 2005). The mechanism of anti-inflammatory 
activity may be related to anti-phlogistic action of tannins 
(Adedapo et al., 2008). In another study, Ahmadiani et al. 
(1998) also reported anti-inflammatory activity of flavor-
noids from Sambucus ebulus rhizome extract. From this 
study, it can, therefore, be concluded that the root extract 
of E. elephantina possess anti-inflammatory and analge-
sic activities, thus giving a scientific basis to its ethno-
veterinary use and acute toxicity results showed that it is 
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